Aditxt, Inc. (ADTX)
NASDAQ: ADTX · Real-Time Price · USD
0.219
-0.031 (-12.25%)
At close: Apr 28, 2026, 4:00 PM EDT
0.217
-0.002 (-0.87%)
After-hours: Apr 28, 2026, 4:28 PM EDT
Aditxt Employees
Aditxt had 26 employees as of December 31, 2024. The number of employees decreased by 21 or -44.68% compared to the previous year.
Employees
26
Change (1Y)
-21
Growth (1Y)
-44.68%
Revenue / Employee
$123
Profits / Employee
-$1,657,748
Market Cap
197.63K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Scinai Immunotherapeutics | 31 |
| BiomX | 20 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| CNS Pharmaceuticals | 5 |
| Adial Pharmaceuticals | 5 |
| Onconetix | 2 |
| Propanc Biopharma | 2 |
ADTX News
- 8 days ago - Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics' RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients - Business Wire
- 5 weeks ago - Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer - Business Wire
- 6 weeks ago - Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection - Business Wire
- 7 weeks ago - Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026 - Business Wire
- 5 months ago - Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta's Planned IPO, And Evofem's Plan to Regain a National Listing - Business Wire
- 6 months ago - Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025 - Business Wire
- 6 months ago - Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market - Business Wire
- 6 months ago - Evofem Announces Voting Results from Special Meeting of Stockholders - PRNewsWire